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BAUER. Regulation of erythropoietin production is related to 
proximal tubular function. Am. J. Physiol. 256 (Renal Fluid 
Electrolyte Physiol. 25): F942-F947,1989.-Regulation of renal 
erythropoietin (EPO) production is based on an intrarenal 
oxygen sensor. Whereas the sensitivity of this oxygen sensor 
to variations in renal oxygen supply is well established, the 
influence of changes in renal oxygen consumption has not yet 
been elucidated. Diuretic drugs, which inhibit active sodium 
reabsorption, reduce tubular oxygen consumption. We there- 
fore investigated the effects of acetazolamide, furosemide, hy- 
drochlorothiazide, and amiloride, known to preferentially in- 
hibit sodium reabsorption at different segments of the nephron, 
on hypoxia-induced EPO formation in mice. Those drugs that 
are considered to act mainly in the loop of Henle, distal tubule, 
and collecting duct (furosemide, hydrochlorothiazide, and amil- 
oride) did not impair EPO formation. Acetazolamide on the 
other hand, which is thought to act predominantly at the 
proximal tubular site, significantly reduced EPO formation in 
response to normobaric hypoxia (8 and 14% 02) and functional 
anemia (0.1% carbon monoxide). This inhibitory effect of ac- 
etazolamide was dose dependent and correlated with the natri- 
uresis induced. It appeared not to depend on the metabolic 
acidosis induced by the drug, since the simultaneous adminis- 
tration of sodium bicarbonate, which restored standard bicar- 
bonate levels to normal, did not diminish the inhibitory effect 
of acetazolamide on EPO production. In conclusion the data 
suggest that the regulation of EPO production is likely to be 
related to proximal tubular function. 
kidney; hypoxia; diuretics; acetazolamide; furosemide; hydro- 
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REGULATION of renal erythropoietin (EPO) production 
is based on a sensing mechanism that detects changes in 
the oxygen content of blood (6). Although the precise 
cellular site of this “oxygen sensor” is yet unknown, 
strong evidence indicates that it is located in the kidney 
itself. Thus isolated perfused kidneys have been shown 
to release more EPO on lowering the oxygen tension of 
the perfusate (5, 9, 15, 26) and selective reduction of 
renal oxygen supply in normoxic animals is able to 
enhance EPO production (10, 22). 
The oxygen-dependent parameter that is perceived by 
the oxygen sensor is likely to be influenced not only by 
renal oxygen supply but also, in an inverse fashion, by 
renal oxygen consumption. The predominant determi- 
nant of renal oxygen consumption is tubular sodium 
reabsorption (3, 13, 17, 24). However, a direct relation- 
ship between EPO production and tubular oxygen con- 
sumption has not yet been established. Recently it has 
been shown that the cells producing EPO are not part of 
the renal tubule itself, but are located in the renal inter- 
stitium (14, 16). The question arises therefore, whether 
or not the regulation of EPO production is at all related 
to tubular function. In addition, if such a relationship 
between tubular function and EPO production exists, it 
seems essential for the understanding of the renal oxygen 
sensor to define the part of the nephron involved in the 
regulation of EPO production. 
To investigate this question, we used diuretic drugs 
with predominant sites of action at different segments 
of the nephron to inhibit sodium reabsorption and there- 
with reduce tubular oxygen consumption. We studied the 
effect of this intervention on the hypoxia-induced EPO 
response in mice. The influence of different diuretics on 
EPO production has to our knowledge so far only been 
investigated by Fisher et al. (8) in 1963. However, these 
investigators chose an entirely different approach, as 
they used cobalt as stimulus for EPO formation. Indirect 
evidence for a role of tubular work in the regulation of 
EPO production was previously provided by Miller and 
co-workers (19). They have demonstrated an inhibitory 
effect of acetazolamide on EPO production in humans 
exposed to simulated altitude. However, in their study a 
potential effect of acetazolamide on sodium reabsorption 
and renal oxygen consumption was not considered. The 
authors attributed the inhibitory effect of acetazolamide 
to prevention of the respiratory alkalosis normally oc- 
curring under hypoxia and an associated rightward shift 
of the oxygen dissociation curve, finally resulting in an 
increased peripheral tissue <oxygenation. 
Employing four different diuretics, our results show 
that furosemide, hydrochlorothiazide, and amiloride, 
which are considered to mainly effect sodium transport 
in the loop of Henle, the distal tubule, and collecting 
duct, respectively, do not impair the hypoxia-induced 
EPO production. On the other hand, acetazolamide that 
is thought to preferentially act at the proximal tubular 
site, significantly reduced EPO formation in close cor- 
relation to the natriuresis induced and independent from 
changes in systemic acid base status. 
MATERIALS AND METHODS 
Male Institute of Cancer Research (ICR) strain mice 
(body wt 25-32 g) were used in this study. 
Hypoxic stimulation of EPO production. Normobaric 
arterial hypoxia or functional anemia caused by carbon 
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monoxide inhalation were used as stimuli for EPO for- 
mation. To this end,- animals were exposed to an atmos- 
phere low in oxygen (8 or 14% 02) or normal air with 
added carbon monoxide (0.1% CO), using chambers that 
were gassed with mixtures of normal atmospheric air and 
nitrogen or carbon monoxide. Animals treated with di- 
uretics and their respective controls were simultaneously 
exposed to the hypoxic stimuli for 3 h. 
Within 15 min after the end of hypoxic exposure 
animals were bled from the retro-orbital sinus under 
ether anesthesia for determination of serum EPO levels 
(see below). 
Experiments with diuretics. To investigate the effect 
of inhibition of sodium absorption at different nephron 
segments on EPO production, the following site-predom- 
inant diuretics (12,21) were used: 1) acetazolamide (Dia- 
mox, Lederle Parenterals, Carolina, PR; proximal tu- 
bule), 2) furosemide (Lasix, Hoechst, Frankfurt, FRG; 
loop of Henle), 3) hydrochlorothiazide (Sigma, St. Louis, 
MO; early distal tubule), and 4) amiloride (Sigma; late 
distal tubule and collecting duct). Solutions for applica- 
tion were prepared as follows: acetazolamide dissolved in 
0.9% NaCl, furosemide diluted with 0.9% NaCl, hydro- 
chlorothiazide dissolved in 0.1 M NaOH and the solution 
then adjusted to pH 6-7 and amiloride dissolved in 
distilled water. A total of 200 ~1 of these solutions con- 
taining 25,100,200, or 500 mg/kg body wt acetazolamide, 
20 mg/kg body wt furosemide, 6 mg/kg body wt hydro- 
chlorothiazide, or 2 mg/kg body wt amiloride, respec- 
tively, were injected into mice 50% intravenously into a 
tail vein and 50% intraperitoneally immediately before 
hypoxic exposure. Control animals were injected with 
200 ~1 of the vehicle only. To quantitate the diuretic 
effect of these drugs, urine voided by five animals each 
within 3 h after application of diuretics was collected in 
metabolic cages and analyzed for sodium content by 
flame photometry (Corning Flame Photometer 410 C, 
Corning Medical, Medfield, MA). 
Experiments with sodium bicarbonate. To compensate 
for the metabolic acidosis induced by acetazolamide, 
animals in a separate set of experiments were injected 
simultaneously with acetazolamide (500 mg/kg body wt) 
and sodium bicarbonate at a dose of 20 mmol/kg (1 M 
solution, injected 50% intraperitoneally and 50% subcu- 
taneously) . Addition al controls were 
same dose of sodium bi -carbonate only. 
treated with the 
Prior to and during all experiments animals had free 
access to tap water. 
Determirkion of EPO. EPO was measured by radio- 
immunoassay (RIA) as described (4), using a rabbit 
antiserum raised against recombinant human EPO and 
iodinated recombinant EPO (Amersham International, 
Amersham, UK) as tracer. A mouse serum pool enriched 
in EPO, prepared by exposing animals to normobaric 
hypoxia for 18 h, was calibrated against human EPO 
(2nd International Reference Preparation, World Health 
Organization) in the polycythemic mouse bioassay (4) 
and used as standard in the RIA (Fig. 1). 
Determination of standard bicarbonate concentrations. 
Animals were anesthetized with 500 mg/kg body wt 5- 
ethyl-5-(1’-methylpropyl)-2-thiobarbituric acid (Inactin, 
Byk-Gulden, Constance, FRG) injected intraperitoneally 
in a concentration of 100 mg/ml. Immediately after onset 
of anesthesia they were bled from the retro-orbital sinus 
into heparinized glass capillary tubes that were then 
instantly transferred to a computerized blood gas ana- 
lyzer (IL 1304, Instrumentation Laboratory, Lexington, 
MA). 
Statistics. Levels of significance were calculated by use 
of Student’s t test. P < 0.05 was considered significant. 
RESULTS 
Kinetics of hypoxia-induced EPO response. Figure 2 
shows the kinetics of serum EPO levels in response 
normobaric hypoxia (7% 02) and functional anemia 
to 
in- 
duced by carbon monoxide inhalation (0.1% CO). Con- 
sistent with previous investigations (2, 20) serum EPO 
levels began to rise l-2 h after the onset of the hypoxic 
stimulus. Independent of the degree of stimulation a 
linear increase of serum EPO levels was observed after 3 
h of hypoxia and this time point was therefore selected 
for further experiments. 
l human EPO (2ndIRP) 
A mouse EPO (serum-pool) 
FIG. 1. Standard curves of the erythropoietin radio- 
immunoassay (EPO RIA), demonstrating cross-reactivity 
of mouse EPO with antiserum derived against recombi- 
nant human EPO. Total amount of antibody-precipitable 
‘251-labeled EPO in absence of unlabeled EPO (Bo) was 
on average 45% of the radioactivity added. 
EPO (mlJ/ml) 
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FIG. 2. Time-dependent increases of serum erythropoietin (EPO) 
levels in response to normobaric hypoxia and carbon monoxide inha- 
lation (mean t SE, n = 5). 
TABLE 1. Effect of diuretics on urine 
and sodium excretion 
Urine Flow, 
Sodium Sodium 
ml/3 h 
Concentration, Excretion, 
mmol/l pmol/3 h 
Controls 
Acetazolamide 
(5OOmg/k) 
Furosemide (20 mg/kg) 
Hydrochlorothiazide 
(6 mg/W 
Amiloride (2 mg/kg) 
0.16 57 9 
0.85 250 213 
1.50 139 209 
0.50 98 49 
0.40 121 48 
Urine was collected from five animals under each condition. Data 
represent the average excretion of one animal within 3 h. 
Effect of diuretics on sodium excretion and urine vol- 
ume. Acetazolamide, furosemide, hydrochlorothiazide, 
and amiloride were used to inhibit sodium reabsorption 
predominantly site specific in the proximal tubule, the 
thick ascending limb of the loop of Henle, the early distal 
tubule, and the late distal tubule and collecting duct, 
respectively. To assess the degree of inhibition of sodium 
reabsorption, the effects of the diuretics on urine volume 
and sodium excretion were measured and the results are 
given in Table 1. All four drugs led to significant diuresis 
and natriuresis. To assess a possible underestimation of 
the effectiveness of acetazolamide caused by compensa- 
tory sodium reabsorption in the more distal parts of the 
nephron, the natriuretic effect of a low dose (25 mg/kg) 
of acetazolamide was also tested in the presence of fu- 
rosemide and hydrochlorothiazide. However, under these 
conditions the acetazolamide-induced increase in natri- 
uresis was not different from the natriuresis brought 
about by acetazolamide alone (41 pmol vs. 40 pmol Na 
per animal within 3 h). 
Effect of diuretics on EPO production. To test any 
direct stimulatory effect of the diuretics on EPO produc- 
tion, which might have compensated a possible reduction 
of hypoxia-induced EPO formation, EPO levels were 
measured in normoxic animals after application of di- 
uretics for 3 h. With acetazolamide (25 or 500 mg/kg), 
hydrochlorothiazide and amiloride EPO levels did not 
change significantly (data not shown), whereas with fu- 
rosemide we observed an increase from 29.5 t 3 to 55.2 
t 12 mu/ml (mean t SE, n = 10; P c 0.005). 
To study the effect of diuretics on hypoxia-induced 
EPO formation, hypoxic stimuli of three different de- 
grees, including two degrees of normobaric arterial hy- 
poxia as well as carbon monoxide inhalation were used. 
The results obtained with carbon monoxide inhalation 
(0.1%) are shown in Fig. 3. With furosemide, hydrochlo- 
rothiazide, and amiloride we found no alteration of the 
hypoxia-induced EPO response compared with control 
animals injected with the vehicle only. Also the combined 
application of furosemide and hydrochlorothiazide did 
not influence EPO formation. With acetazolamide (500 
mg/kg), however, there was a significant reduction of the 
EPO response (P < 0.001). 
A similar inhibitory effect of acetazolamide on EPO 
production was observed in response to both degrees of 
arterial hypoxia (8% 02 and 14% 02). (Fig. 4, left). In 
contrast, furosemide and hydrochlorothiazide, either 
alone or in combination, and amiloride did not reduce 
the EPO response (Table 2). With furosemide there was 
even a slight, but significant increase in response to both 
stimuli. 
Figure 4 (right) shows that the inhibitory effect of 
acetazolamide on EPO production in response to nor- 
mobaric hypoxia (8% 02) was dose dependent; whereas 
25 and 100 mg/kg did not change EPO production sig- 
nificantly, EPO levels were significantly reduced after 
administration of 200 and 500 mg/kg (P c 0.025 and P 
< 0.001, respectively). In contrast the effect of acetazol- 
amide on acid-base status of the animals was not dose 
dependent over the same range of concentrations, as 
demonstrated in Fig. 5, top. Both 25 and 500 mg/kg body 
wt led to a significant reduction of sodium bicarbonate 
concentrations (P c 0.01) that was, however, not differ- 
900 
p < 0.001 
k 1 
control AC control FU c ntrol HCT control FU+ control AM 
HCT 
FIG. 3. Serum erythropoietin (EPO) levels after 3 h exposure to 
carbon monoxide (0.1%) in animals treated with acetazolamide (AC), 
furosemide (FU), and hydrochlorothiazide (HCT), either alone or in 
combination (FU+HCT), and amiloride (AM). Respective controls, 
injected with vehicle only, were simultaneously exposed to hypoxia 
(means t SE, n = 5-12). 
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TABLE 2. Serum EPO levels (mU/ml) after 3 h exposure 
to normobaric arterial hypoxia in control animals 
and animals treated with diuretics 
14% 02 8% 02 
Control Dwz Control Dwi4 
Furosemide (20 mg/kg) 98t19 121t13* 265k97 317t23* 
(10) (5) (2% (30) 
Hydrochlorothiazide 104t29 97t30 314&60 300t27 
(6 w/W (5) (5) (5) (5) 
Furosemide (20 mg/kg) + 91t18 91t,16 275t27 283&27 
hydrochlorothiazide (10) (10) (20) (20) 
(6 mg/W 
Amiloride (2 mg/kg) 104t29 lllk58 286t40 28Okc-28 
(5) (5) (15) (15) 
Values are means t SE; values in parentheses are no. of animals. 
EPO, erythropoietin. * P < 0.05. 
ent between the two doses. Furthermore, simultaneous 
application of sodium bicarbonate together with acet- 
azolamide, which restored standard bicarbonate levels to 
at least normal concentrations (Fig. 5, top), did not 
diminish the inhibitory effect of acetazolamide on EPO 
production in response to hypoxia (8% 02) (Fig. 5, bot- 
tom). Sodium bicarbonate per se did not significantly 
alter the hypoxia-induced EPO formation (Fig. 5, bot- 
tom). Figure 6 demonstrates that the inhibitory effect of 
acetazolamide on EPO production paralleled the natri- 
uresis brought about with the different doses of the drug. 
DISCUSSION 
This study was aimed at investigating the effect of 
inhibition of tubular sodium reabsorption in different 
parts of the nephron on the hypoxia-induced renal EPO 
formation. To this end we used diuretic drugs that are 
known to block sodium reabsorption preferentially in the 
proximal tubule (acetazolamide), the thick ascending 
limb of the loop of Henle (furosemide), the early distal 
tubule (hydrochlorothiazide), and the late distal tubule 
and collecting duct (amiloride) (12, 21). We explicitly 
assume that an inhibition of sodium reabsorption is 
associated with a decrease in tubular oxvgen consump- 
250 
FIG. 4. Effect of acetazolamide (500 mg/kg) on eryth- 
200 
ropoietin (EPO) production in response to different de- 
grees of normobaric arterial hypoxia (left) and effect of 
different doses of acetazolamide on EPO production in 
150 
response to normobaric arterial hypoxia (8% 02) (right) 
(means k SE, n = 10-20). EPO levels under acetazolamide 
were significantly different from untreated controls with 
100 a dose of 500 mg/kg at 8% (P < 0.001) and 14% 02 (P < 
0.001) and with a dose of 200 mg/kg at 8% 02 (P < 0.025). 
+ ---a-----w--m------- -- 
m<: 
A AC (25mg/kg) 
0 AC (500mg/kg) X +, SEM; n-5 
0 NaHC03 (20mmoVkg) 
@AC (500mg/kg) + NaHC0,(20mmol/kg) 
0 1 2 
time after injection (h) 
3 
control AC control AC control AC control NaHCO, 
(25mg/kg) (500mgIkg) (500mgIkg) (20mmoVkg) 
NakO, 
(20mmoVkg) 
FIG. 5. Effect of acetazolamide (AC; 25 or 500 mg/kg), sodium 
bicarbonate (NaHCO,; 20 mmol/kg) and combined application of AC 
and NaHC03 (20 mmol/kg) on standard bicarbonate concentrations 
(top) and erythropoietin (EPO) formation in response to 8% 02 (bot- 
tom). *P < 0.025; **P < 0.01; *** P < 0.005; O P < 0.001 vs. controls. 
tion. This assumption is supported by a number of ex- 
periments in which a positive and linear relationship was 
established between the amount of sodium reabsorbed 
and renal oxygen consumption (3, 13, 17, 24). 
Interpretation of the effect of the diuretics used in the 
present study on EPO formation requires an estimate of 
the efficacy with which sodium reabsorption was blocked 
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FIG. 6. Dose-response relationship of acetazolamide with respect to 
inhibition of erythropoietin (EPO) production and urinary sodium 
excretion. 
at the respective segments of the nephron. Such an 
estimate can be made on the basis of the data on sodium 
excretion in controls and in animals receiving diuretics 
(Table 1). Assuming that sodium excretion of control 
animals corresponds to 1% of their filtered sodium load, 
an approximate calculation of fractional sodium excre- 
tion under the different diuretics can be computed by 
relating the absolute sodium excretion of animals with 
diuretic treatment to that of controls (Table 3, top half). 
A comparison of these figures with the fraction of sodium 
normally reabsorbed at the different parts of the nephron 
(11,21) (Table 3, bottom halfi reveals that with amiloride, 
hydrochlorothiazide, and furosemide in the doses used, 
sodium reabsorption was intensively blocked in the col- 
lecting duct, distal tubule, and thick ascending limb of 
the loop of Henle. 
Nevertheless, the EPO response to mild and severe 
hypoxia was not reduced under each of these three di- 
uretics (Table 2, Fig. 3). Also the combined application 
of furosemide and hydrochlorothiazide did not blunt the 
EPO response, thus excluding the possibility of masking 
a potential effect of furosemide on EPO production by a 
compensatory increase of distal tubular reabsorption 
rate. How furosemide led to a slight increase of basal as 
well as stimulated EPO levels in response to arterial 
hypoxia (Table 2) cannot be explained on the basis of 
the present investigation. However, furosemide is known 
to increase renal prostaglandin formation (1, 26), and 
prostaglandins have been shown to stimulate EPO pro- 
duction (7). 
In contrast to the results obtained with diuretics acting 
in the loop of Henle and more distal parts of the nephron, 
we found a significant reduction of hypoxia-induced EPO 
formation after administration of acetazolamide, a di- 
uretic that is considered to act predominantly at the 
proximal tubular site (12, 21), using a dose of 200 or 500 
mg/kg (Figs. 3 and 4). It should be noted that doses of 
acetazolamide given to humans are severalfold lower on 
a dose per kilogram body weight basis. However, natri- 
uresis achieved with the low doses used in clinical routine 
usually does not exceed 5% of the filtered sodium load 
(12). In contrast, with the dosage of 500 mg acetazol- 
amide/kg, up to which a linear log dose-response rela- 
tionship has previously been established for the drug 
(18), fractional sodium excretion corresponded to ap- 
proximately one-third of normal proximal tubular so- 
dium reabsorption (Table 3). Two established effects of 
acetazolamide are likely to reduce the oxygen demand of 
the proximal tubule. First, the drug directly interferes 
with reabsorptive function by inhibiting carbonic anhy- 
drase and second, it diminishes reabsorption rate indi- 
rectly by reducing the filtered solute load via activation 
of the tubuloglomerular feedback system (12,21). At the 
same time urinary bicarbonate loss leads to a reduction 
in plasma bicarbonate concentrations. Miller and co- 
workers (19)) who previously demonstrated an inhibitory 
effect of acetazolamide on EPO production in humans, 
attributed this effect to changes in the acid base status. 
The authors concluded that acetazolamide treatment 
prevented the respiratory alkalosis, normally occurring 
under hypoxic conditions, and thereby prevented a left- 
ward shift in the oxygen dissociation curve, finally re- 
sulting in an increased peripheral tissue oxygenation. 
These investigators did not consider a potential effect of 
acetazolamide on sodium reabsorption. However, it has 
been demonstrated that a comparable dose of acetazol- 
amide administered to humans causes a 30% rise in 
lithium clearance (23), thus indicating a considerable 
inhibition of proximal tubular sodium reabsorption. To 
further distinguish the possible mechanism by which the 
reduction in EPO response could have been mediated in 
our experiments, we intended to compensate for the 
metabolic acidosis, but not the natriuretic effect of the 
drug, by simultaneous treatment with acetazolamide and 
high doses of sodium bicarbonate. This regime resulted 
in normal or even slightly enhanced standard bicarbon- 
ate concentrations (Fig. 5, top). Nevertheless, the inhib- 
itory effect of acetazolamide was not diminished by the 
simultaneous application of sodium bicarbonate (Fig. 5, 
bottom). Furthermore, the metabolic acidosis with low 
TABLE 3. Fractional sodium excretion under diuretics and normal sodium reabsorption 
at respective site of diuretic action 
Acetazolamide, 
500 mg/kg 
Furosemide, 
20 w/k 
Hydrochlorothiazide, 
6 wdk 
Amiloride, 
2 w/k 
Estimate of fractional sodium 
excretion 
Normal sodium reabsorption at 
respective site of diuretic action 
24% 23% 5% 5% 
50-60% 25-40% EL10% 8-10% l-2% 
(proximal tubule) (loop of Henle) (distal tubule) (distal tubule) (collecting duct) 
Fractional sodium excretions under diuretics were calculated from the absolute values of sodium excretion (Table l), assuming that in animals 
not treated with diuretics (controls in Table 1) fractional sodium excretion corresponded to 1% of the filtered load. Values for normal sodium 
reabsorption at respective site of diuretic action were taken from Refs. 11 and 21. 
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doses of acetazolamide, which were ineffective with re- * 
gard to EPO production, was not different from that at 
high doses, which significantly reduced EPO formation 
(Fig. 5, top), also indicating that both phenomena did 5 
not depend on each other. Although these findings sug- 
gest that the effect of acetazolamide on EPO formation 6* 
was not mediated by systemic acidosis, we cannot defi- 
nitely rule out a local acidosis at the proximal tubular 
7 
l 
site or a side effect of the drug on the EPO-producing 8. 
cells. Presently, however, it is not possible to investigate 
a direct effect on the EPO-producing cells, since they 
have not yet been identified unequivocally. On the other 
9 
l 
hand, the inhibitory effect of acetazolamide on EPO 
formation strictly paralleled the natriuresis induced (Fig. 10. 
6) and it seems reasonable therefore to assume that the 
reduction of EPO formation is most likely related to a 
direct effect on the proximal tubule. 
11 . 
Recently Lacombe et al. (16) and Koury et al. (14) 
demonstrated the existence of messenger RNA for EPO 
in peritubular cells in the renal cortex and to a lesser 12* 
extent in the outer medulla by using in situ hybridization. 
This location of the EPO-producing cells fits with a 13. 
possible involvement of the proximal tubule in the reg- 
ulation of EPO production, as inferred from the present 14* 
study. It is not known at present whether the EPO- 
producing cells themselves are sensitive to hypoxia. In 15 
l this case the function of the proximal tubule would be to 
lower the oxygen tension in the surrounding renal inter- 
stitium. Alternatively the proximal tubule could also X* 
generate a biochemical signal that stimulates EPO for- 
mation in the EPO-producing cells being located in its 
immediate vicinity. 
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